0       0

2020 Volunteer Leadership Conference


Future of CFTR Modulators


Mar 14, 2020 1:15pm ‐ Mar 14, 2020 2:15pm

Description

The approval of the triple-combination modulator, elexacaftor/tezacaftor/ivacaftor (Trikafta™), is an exciting milestone, but does not end our search for new CFTR modulators. This presentation will provide an overview of the current modulator landscape, including potential new modulators in the pipeline. We’ll also preview several studies, including studies in younger people with CF, studies to better understand the effects of modulators on CF, and studies to evaluate whether people with CF can reduce their treatment burden once on highly effective modulators.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content